FDA Drug Shortage Database
Sufentanil (Sufenta) shortage
The FDA Drug Shortage Database lists 3 of 4 sufentanil presentations as limited or unavailable (updated September 22, 2026); the first entry was posted on May 3, 2022. 1 more presentation is on the list as available.
- Generic listed
- In shortage
- Boxed warning
- DEA Schedule II
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 1ml injection | 0 | 1 | 0 |
| 50mcg/1ml injection | 3 | 0 | 0 |
Which presentations are listed?
Limited or unavailable now (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Hikma Pharmaceuticals USA, Inc. | Current posted May 3, 2022, updated September 18, 2026 | Unavailable; Other |
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Hikma Pharmaceuticals USA, Inc. | Current posted May 3, 2022, updated September 18, 2026 | Unavailable; Other |
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Hikma Pharmaceuticals USA, Inc. | Current posted May 3, 2022, updated September 18, 2026 | Unavailable; Other |
Listed now, available (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Hospira, Inc., a Pfizer Company | Current posted May 3, 2022, updated September 22, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage